Flex Pharma to Report First Quarter 2016 Results on May 4, 2016
April 27 2016 - 8:00AM
Business Wire
Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company
developing innovative and proprietary treatments for nocturnal leg
cramps (NLC), spasms associated with severe neuromuscular
conditions such as MS and ALS, and exercise-associated muscle
cramps, announced today that it will report its financial results
for the first quarter ended March 31, 2016 on Wednesday, May 4,
2016 before the U.S. financial markets open. The Company will host
a conference call and webcast at 8:45 a.m. ET to discuss first
quarter 2016 financial results and provide a business update.
Individuals interested in participating in the call should dial
(855) 780-7202 (U.S. and Canada) or (631) 485-4874
(International).
A live webcast may be accessed in the Investors section of the
Company's website at www.flex-pharma.com. Please log on to the Flex
Pharma website approximately 15 minutes prior to the scheduled
webcast to ensure adequate time for any software downloads that may
be required. A replay of the webcast will be available on Flex
Pharma's website for three months.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for nocturnal leg cramps,
spasms associated with severe neuromuscular conditions such as MS
and ALS, and exercise-associated muscle cramps. Flex Pharma was
founded by National Academy of Science members Rod MacKinnon, M.D.
(2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in
the fields of ion channels and neurobiology, along with Chair and
CEO Christoph Westphal, M.D., Ph.D.
Follow Flex Pharma on Twitter (@flexpharma) and visit the
Company’s web site (http://ir.flex-pharma.com/) for updates of the
Company's pre-launch activities for its consumer product to prevent
and treat exercise-associated muscle cramps.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160427005186/en/
Flex Pharma, Inc.Elizabeth Woo, 617-874-1829SVP, Investor
Relations & Corporate Communicationsirdept@flex-pharma.com
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Jun 2024 to Jul 2024
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Jul 2023 to Jul 2024